Other

Long-term debt interest payments - 2026

Merck & Co. Long-term debt interest payments - 2026 increased by 50.0% to $1.50B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 50.0%, from $1.00B to $1.50B. Over 4 years (FY 2021 to FY 2025), Long-term debt interest payments - 2026 shows an upward trend with a 19.2% CAGR.

Analysis

StatementBalance Sheet Statement
SectionOther
First reportedQ4 2021
Last reportedQ4 2025
Metric ID: long_term_debt_interest_payments_2026

Historical Data

5 periods
 Q4 '21Q4 '22Q4 '23Q4 '24Q4 '25
Value$743.00M$720.00M$1.00B$1.00B$1.50B
QoQ Change—-3.1%+38.9%+0.0%+50.0%
YoY Change—-3.1%+38.9%+0.0%+50.0%
Range$720.00M – $1.50B
CAGR+101.9%
Avg YoY Growth+21.4%
Median YoY Growth+19.4%
Current Streak3 quarters growth

Frequently Asked Questions

What is Merck & Co.'s long-term debt interest payments - 2026?
Merck & Co. (MRK) reported long-term debt interest payments - 2026 of $1.50B in Q4 2025.
How has Merck & Co.'s long-term debt interest payments - 2026 changed year-over-year?
Merck & Co.'s long-term debt interest payments - 2026 increased by 50.0% year-over-year, from $1.00B to $1.50B.
What is the long-term trend for Merck & Co.'s long-term debt interest payments - 2026?
Over 4 years (2021 to 2025), Merck & Co.'s long-term debt interest payments - 2026 has grown at a 19.2% compound annual growth rate (CAGR), from $743.00M to $1.50B.

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.